Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap12
Identity of virulence factors
Dependencies
- 13 Identity of virulence factors
- 14 Identity of immunomodulators
- 15 Host responses to natural infection
- 16 Identity of mechanisms of protection
- 16A Antibody response
- 16B Cell-mediated immunity
Next steps
- 9 Adjuvant
- 10 Expression system
- 11 Vector
Identity of protective antigens
Research Question
- The identity of the virus components (epitopes) that the host needs to respond to to prevent and clear infection
Research Gaps and Challenges
- The dominant immunogens may not be protective so a range of possible antigens will need to be considered
- There is a lot of antigenic variability and genetic drift from the high mutation rate of the virus so identifying the most stable/conserved antigens is important
Solution Routes
- The identity of the antigens that the host is generating Abs to and their role in protection (preventing and clearing infection)
- To identify the antigens that are responsible for protective cellular responses
- Identifying possible protective antigens in the virus genome, their expression and trial in challenge experiments
Dependencies
- Identity of protective mechanisms operating in immune hosts – the role of neutralising Abs and CTCs
- The genome sequence of various virus isolates
Projects
What activities are planned or underway?
Generating antibodies broadly neutralising porcine reproductive and respiratory syndrome virus (PRRSV)
Planned Completion date 31/12/2025
Source Countries:
Denmark
Identification of interferon stimulated genes that control Toxoplasma in pig macrophages
Planned Completion date 01/03/2026
Source Countries:
United Kingdom